Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Taymaa May, M.D.

Concepts (247)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms56202448727.050 Why?
Cystadenocarcinoma, Serous1920244796.520 Why?
Neoadjuvant Therapy18202428092.560 Why?
Indocyanine Green320242322.120 Why?
Chemotherapy, Adjuvant16202435101.920 Why?
CA-125 Antigen420242791.920 Why?
Genital Neoplasms, Female720245321.920 Why?
Fluorescein Angiography3202410431.650 Why?
Anastomosis, Surgical220249791.290 Why?
Gynecologic Surgical Procedures420242841.280 Why?
Neoplasms, Glandular and Epithelial520224871.230 Why?
Fallopian Tube Neoplasms520223280.960 Why?
Endometrial Neoplasms9202213560.950 Why?
Neoplasm Staging192024110820.900 Why?
Uterine Cervical Neoplasms6202420060.900 Why?
Carcinoma6202223300.850 Why?
Digestive System Surgical Procedures320215730.760 Why?
Hospitals, Private12021630.740 Why?
Hysterectomy620218520.710 Why?
Hospitals, Public120212010.670 Why?
BRCA1 Protein5202411470.650 Why?
Laparoscopy3202120320.650 Why?
Cisplatin2202116470.600 Why?
Canada9202221090.600 Why?
Adnexal Diseases120191050.600 Why?
Retrospective Studies362024799840.590 Why?
Genes, BRCA2220186030.570 Why?
Ovary120219580.550 Why?
Genes, BRCA1220187650.550 Why?
Female8420243899430.540 Why?
Rhabdomyosarcoma120183580.510 Why?
Lymph Node Excision3202112770.500 Why?
Laparotomy120174540.470 Why?
Choriocarcinoma220131210.470 Why?
Antineoplastic Agents42021135970.460 Why?
Hematologic Diseases120184960.450 Why?
Germ-Line Mutation2202118410.440 Why?
BRCA2 Protein420247980.430 Why?
Mixed Tumor, Mullerian12012550.420 Why?
Neoplasm Recurrence, Local9202492450.420 Why?
Alcohol Oxidoreductases120131690.410 Why?
Intestines1202119070.390 Why?
Middle Aged3920242191920.380 Why?
Cohort Studies162024411900.370 Why?
Humans8220247575660.360 Why?
Injections, Intraperitoneal220214120.350 Why?
Sinus Thrombosis, Intracranial120111100.340 Why?
Antineoplastic Combined Chemotherapy Protocols72024117090.330 Why?
Organoplatinum Compounds320204060.330 Why?
Carcinoma, Papillary220147840.310 Why?
Aged2920241678900.310 Why?
Adult3120242197250.280 Why?
Neoplasm, Residual3202310050.280 Why?
Uterine Neoplasms2201314140.260 Why?
Aged, 80 and over152024585580.250 Why?
Sentinel Lymph Node Biopsy220217350.240 Why?
Kaplan-Meier Estimate4202364700.230 Why?
Ileostomy120241210.230 Why?
Coloring Agents120245590.200 Why?
Genome-Wide Association Study72024126010.200 Why?
Neurofibrosarcoma12021260.190 Why?
Urinary Retention120221060.190 Why?
Young Adult102024587550.180 Why?
Fallopian Tubes420221770.180 Why?
Nerve Tissue Proteins1201344070.180 Why?
Carcinoma, Endometrioid220142760.170 Why?
Genetic Predisposition to Disease92024177670.170 Why?
Epigenesis, Genetic1201337520.170 Why?
Poly(ADP-ribose) Polymerases220134250.170 Why?
Vaginal Neoplasms120201040.170 Why?
Ontario420213970.160 Why?
Glucuronosyltransferase120191300.160 Why?
Survival Rate52021126840.150 Why?
Tumor Burden2202118860.150 Why?
Cancer Care Facilities120214190.150 Why?
Gynecology220215230.150 Why?
Endometrium120204020.150 Why?
Vulvar Neoplasms120202630.140 Why?
Drug Administration Schedule3202048450.140 Why?
Carcinoma, Adenosquamous12017660.140 Why?
Gene Expression Regulation, Neoplastic1201385030.140 Why?
Markov Chains120209650.140 Why?
Peritoneal Neoplasms120237070.140 Why?
Polymorphism, Single Nucleotide82024157740.140 Why?
Inheritance Patterns120193400.140 Why?
Receptors, Calcitriol120193590.140 Why?
Intracellular Signaling Peptides and Proteins2202128680.130 Why?
Models, Economic120207150.130 Why?
Intraoperative Care120207640.130 Why?
Survival Analysis32024100750.130 Why?
Urinary Tract Infections120228060.130 Why?
Pelvis220177320.130 Why?
Postoperative Care1202114680.120 Why?
Endometriosis220148600.120 Why?
Quality Improvement5202437930.120 Why?
Communicable Disease Control120218420.120 Why?
Mutation62024299290.120 Why?
Radiotherapy1202114980.120 Why?
Adenocarcinoma3201763230.120 Why?
Triage120219830.110 Why?
Proportional Hazards Models22018123970.110 Why?
Cell Line, Tumor32021168810.110 Why?
Antineoplastic Agents, Hormonal1202115160.110 Why?
Vaginal Smears120164990.110 Why?
Co-Repressor Proteins120131910.100 Why?
Patient Discharge2202434280.100 Why?
Lymphocytes1202026100.100 Why?
MutS Homolog 2 Protein120121950.100 Why?
Adenocarcinoma, Clear Cell120142170.100 Why?
Neoplasms, Multiple Primary220145860.100 Why?
Myometrium120121740.100 Why?
Pain, Postoperative1202117150.090 Why?
Pregnancy Complications, Neoplastic120132550.090 Why?
Disease Models, Animal22021181140.090 Why?
Methionine120135690.090 Why?
Phthalazines120133820.090 Why?
Decision Support Techniques1202019910.090 Why?
Preoperative Care1201922460.090 Why?
Brain Neoplasms1201189810.080 Why?
Cyclin-Dependent Kinase 2120101840.080 Why?
Medical Oncology1202123080.080 Why?
Time Factors32021398110.080 Why?
Combined Modality Therapy2202185120.080 Why?
Sensitivity and Specificity32021146370.080 Why?
Gene Knockdown Techniques1201316090.080 Why?
Glucocorticoids1201821440.080 Why?
Gene Expression Profiling3201894030.080 Why?
Genetic Testing1202135290.070 Why?
Neutrophils1202037560.070 Why?
Genetic Loci1201726120.070 Why?
Cost-Benefit Analysis1202054830.070 Why?
Patient Care Team1201825050.070 Why?
Membrane Proteins1202478400.070 Why?
Wound Healing1201827810.070 Why?
Prospective Studies52023540920.060 Why?
Analgesics, Opioid1202137620.060 Why?
Postoperative Complications42024155320.060 Why?
Disease Progression12021134630.060 Why?
Apoptosis Regulatory Proteins1201011330.060 Why?
DNA Methylation1201843720.060 Why?
Head and Neck Neoplasms1201928810.060 Why?
Latent TGF-beta Binding Proteins12024430.060 Why?
Multivariate Analysis12017120470.060 Why?
Cell Survival1201357810.050 Why?
Risk Factors82024737080.050 Why?
Practice Guidelines as Topic2202173660.050 Why?
Breast Neoplasms22022209920.050 Why?
Reverse Transcriptase Polymerase Chain Reaction1201045650.050 Why?
Piperazines1201325110.050 Why?
High-Throughput Nucleotide Sequencing1201536140.050 Why?
Bayes Theorem2202223180.050 Why?
Promoter Regions, Genetic1201357780.050 Why?
Carcinoma, Squamous Cell1201740190.050 Why?
Urinary Catheterization120221940.050 Why?
Melanoma1202056890.050 Why?
Lymphatic Metastasis2202129140.050 Why?
Quantitative Trait Loci2202021000.050 Why?
Neoplasm Seeding12021840.050 Why?
Pandemics1202186000.050 Why?
Urination120222020.050 Why?
Phosphoproteins1201024320.050 Why?
Mitogen-Activated Protein Kinase Kinases120236400.050 Why?
Fibrinogen120248830.040 Why?
Infusions, Parenteral120203980.040 Why?
Vulva12020820.040 Why?
Chemotherapy, Cancer, Regional Perfusion12020920.040 Why?
Predictive Value of Tests32021152070.040 Why?
Adaptor Proteins, Signal Transducing1201028910.040 Why?
Body Mass Index12017128680.040 Why?
Colorectal Neoplasms1201968400.040 Why?
Alleles2202268940.040 Why?
Gene Knockout Techniques120218020.040 Why?
Area Under Curve1202216320.040 Why?
Randomized Controlled Trials as Topic32020101350.040 Why?
Preoperative Period120205490.040 Why?
Carboplatin120217920.040 Why?
Prognosis42021294880.040 Why?
Adolescent32021878190.040 Why?
Oncogenes1202312220.040 Why?
Case-Control Studies32024220220.040 Why?
Mice22021810660.040 Why?
Perioperative Period120182490.030 Why?
Mass Spectrometry1202421900.030 Why?
Animals420211677180.030 Why?
Hyperthermia, Induced120204160.030 Why?
Telomere-Binding Proteins120171190.030 Why?
Immunohistochemistry12010110630.030 Why?
Glycoproteins1202422050.030 Why?
Prostatic Neoplasms12019110570.030 Why?
Receptors, Glucocorticoid120182950.030 Why?
United States22021719020.030 Why?
Child, Preschool12018420450.030 Why?
Diagnosis, Differential12011129510.030 Why?
Tomography, X-Ray Computed12019204990.030 Why?
Postoperative Period1202018060.030 Why?
Treatment Outcome32018642420.030 Why?
Morbidity1202017480.030 Why?
SEER Program1202014540.030 Why?
Hong Kong120151670.030 Why?
Vagina120208280.030 Why?
Lung Neoplasms12019132680.030 Why?
Incidental Findings120196930.030 Why?
Taxoids120176660.030 Why?
DNA Copy Number Variations1202220120.030 Why?
Paclitaxel1202117310.030 Why?
Genotype22018129510.030 Why?
Pregnancy22013297120.030 Why?
Hydrops Fetalis120131090.030 Why?
MAP Kinase Signaling System1202014770.030 Why?
Term Birth120131400.030 Why?
Algorithms22023139520.030 Why?
Meta-Analysis as Topic1201713730.020 Why?
Neoplasm Invasiveness1202035910.020 Why?
Histocytochemistry120126990.020 Why?
Chorionic Gonadotropin120134570.020 Why?
New England1201310510.020 Why?
Disease-Free Survival1202068070.020 Why?
Stillbirth120133680.020 Why?
Genetic Association Studies1201927170.020 Why?
Live Birth120135120.020 Why?
Quality of Life22021132630.020 Why?
Women's Health1201820550.020 Why?
Patient Selection1202142350.020 Why?
Papillomaviridae1201511200.020 Why?
Models, Genetic1201834410.020 Why?
Biopsy1202067570.020 Why?
Length of Stay1202263840.020 Why?
Neoplasm Metastasis1201948860.020 Why?
Genomics1202457880.020 Why?
Neoplasm Proteins1201936080.020 Why?
Risk1201895900.020 Why?
Heterozygote1201227970.020 Why?
Lymph Nodes1201734700.020 Why?
Academic Medical Centers1201627420.020 Why?
Vitamin D1201932820.020 Why?
Logistic Models12019132210.010 Why?
Drug Resistance, Neoplasm1201852530.010 Why?
Massachusetts1201688150.010 Why?
Smoking1201990360.010 Why?
Phenotype12019165330.010 Why?
Follow-Up Studies12021390200.010 Why?
Mass Screening1201654120.010 Why?
Mice, Inbred C57BL12018219900.010 Why?
Mental Disorders1201968020.010 Why?
Risk Assessment12020238160.010 Why?
Child12020797820.010 Why?
Male120193581800.000 Why?
May's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (247)
Explore
_
Co-Authors (38)
Explore
_
Similar People (58)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.